Calamos Investments, a US-based investment management firm, has agreed to acquire Phineus Partners, an alternative asset specialist based in San Francisco.
Financial terms of the deal, which is scheduled to close in the coming weeks, have not been disclosed.
Go deeper with GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
Established in 2002 by Michael Grant, Phineus is an investment firm, which employs a blend of bottom-up and top-down considerations.
Calamos said: "We are pleased to welcome Michael and his team to Calamos Investments. As one of the first entrants into the liquid alternative space more than twenty years ago, we continue to expand our presence in the space. Michael’s strategy will be a welcome addition to our lineup."
Additionally, Calamos has moved its investment team to a structure headed by John Calamos, Sr and four senior portfolio managers.
The firm has also hired Robert Behan as new president, who will be responsible for managing the firm’s business execution, strategic growth initiatives, and corporate development. He will also continue to remains as head of global distribution.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMoreover, four senior members of the investment team have been appointed as co-chief investment officers namely John Hillenbrand, David Kalis, Nick Niziolek and Eli Pars. They will lead the investment department and their respective strategies, including investment personnel.
Gary Black, global co-chief investment officer, who was responsible for implementing the plan to deepen and develop the Calamos investment department into specialized teams, will move from the firm by 31 October 2015.
"Starting with the goal of building deeper research capabilities within more specialized teams, we have committed significant resources to the investment department in recent years," said Calamos.
